Skip to main content

Table 2 Characteristics of patients with detected mutations

From: Selected AGXT gene mutations analysis provides a genetic diagnosis in 28% of Tunisian patients with primary hyperoxaluria

Characteristics of patients

I244T mutation* N = 17

33_34insC mutation* n = 8

Median and [range ] of ages of onset (years)

12 [0.25 - 38]

3[0.33 - 61]

Oxalate/creat (mmol/mmol)

0.6 ± 0.95

0.17 ± 0.15

Different ages of onset

(number of patients)

%

   < 1 yr

(2)

11.7

(1)

12.5

   2-5 yr

(5)

29.4

(6)

75

   10-20 yr

(7)

41.1

-

   > 20 yr

(3)

17.6

(1)

12.5

Consanguinity

(12)

70.5

(8)

100

Renal insufficiency

(13)

76.4

(7)

87.5

with nephrocalcinosis only

(3)

17.6

(0)

0

with urolithiasis

(3)

17.6

(6)

75

   with both nephrocalcinosis and urolithiasis

(4)

23.5

(1)

12.5

   Data not done

(3)

17.6

-

-

ESRD

(13)

76.4

(7)

87.5

   Hemodialysis

(11)

64.7

(7)

87.5

   Peritoneal Dialysis

(2)

11.7

(0)

0

Preserved renal function

(4)

23.5

(1)

12.5

Systemic symptoms

(4)

23.5

(2)

25

Mortality

(5)

29.5

(5)

62.5

  1. * All patients with homozygote and heterozygote mutations were considered; The patient carrying compound heterozygote mutations (I244T and 33_34ins) was considered in the two columns
  2. **Characteristic of patients with homozygote mutations are described in Additional file 2, Table S2.